Stifel Initiates Coverage On Tectonic Therapeutic with Buy Rating, Announces Price Target of $75

Benzinga Newsdesk www.benzinga.com Positive 65.4%

Neg 0% Neu 0% Pos 65.4%

Stifel analyst James Condulis initiates coverage on Tectonic Therapeutic (NASDAQ:TECX) with a Buy rating and announces Price Target of $75.